Scientists have described an improved, cost-efficient method to isolate membrane proteins, a class of proteins that are the targets of more than 60 percent of approved therapeutic drugs.
Cell & Microbiology
Jul 25, 2016
0
5
Scientists using a technology called cryo-EM (cryo-electron microscopy) have broken through a technological barrier in visualizing proteins with an approach that may have an impact on drug discovery and development. They ...
Biochemistry
May 26, 2016
0
191
Researchers have developed a light-activated tool to show how drugs need to be adapted to combat type 2 diabetes.
Biochemistry
Apr 11, 2016
1
30
If you suffer from atrial fibrillation (AF)—a condition where disorganized electrical signals cause the heart's upper chambers to contract quickly and irregularly—your doctor may prescribe an antiarrhythmic drug. While ...
Cell & Microbiology
Feb 29, 2016
0
11
Natural selection results in protein sequences that are only soluble to the level that is required to carry out its physiological function. However, in biotechnological applications, we need these proteins to survive concentrations ...
Cell & Microbiology
Feb 29, 2016
0
7
Researchers from Carnegie Mellon University (CMU) have created the first robotically driven experimentation system to determine the effects of a large number of drugs on many proteins, reducing the number of necessary experiments ...
Cell & Microbiology
Feb 9, 2016
0
13
A new study shows that it is possible to use an imaging technique called cryo-electron microscopy (cryo-EM) to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells. The cryo-EM ...
Biochemistry
Jan 29, 2016
0
20
Tracking the path of chemotherapy drugs in real time and at a cellular level could revolutionize cancer care and help doctors sort out why two patients might respond differently to the same treatment.
Bio & Medicine
Jan 14, 2016
0
637
Researchers at the University of Waterloo have discovered a new way to create designer proteins that have the potential to transform biotechnology and personalized medicines.
Biotechnology
Nov 24, 2015
0
29
Purdue researchers have devised a way to capture the finer details of complex cell processes by using tiny synthetic particles known as dendrimers, a technology that could lead to more targeted treatment for cancer.
Bio & Medicine
Nov 11, 2015
1
34
